Australia's inflation rate falls from 2.4 per cent to 2.1 per cent, Cochlear calls for R&D investment changes. Plus, ResMed CEO Mick Farrell joins the show as his company overcomes the threat from Ozempic.
See omnystudio.com/listener for privacy information.
Comments (3)
More Episodes
All Episodes>>
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
